Trial intelligence / Profile preview

Phase III study of lyophilized live attenuated human rotavirus vaccine in healthy Japanese infants

2015-001543-36Phase 3

Sponsor
GSK
Start
Jun 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in rotaviral diarrhea comparing HRV vaccine with Placebo (2 arms).

02

Drugs

human rotavirus RIX4414 strain vaccine
03

Conditions

rotaviral diarrhea

Beyond the preview

Go deeper on 2015-001543-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001543-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call